Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
19.75
+0.05 (0.25%)
Jul 29, 2026, 9:33 AM EDT - Market open
Jade Biosciences Employees
Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year.
Employees
55
Change
25
Growth
83.33%
Revenue / Employee
n/a
Profits / Employee
-$1,729,036
Market Cap
1.17B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 25 | 83.33% |
| Dec 31, 2024 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 678 |
| MannKind | 592 |
| Ardelyx | 489 |
| MeiraGTx Holdings | 409 |
| Wave Life Sciences | 317 |
| Absci | 140 |
| Inhibrx Biosciences | 110 |
JBIO News
- 4 weeks ago - Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors - GlobeNewsWire
- 6 weeks ago - Jade Biosciences initiated with a Buy at UBS - TheFly
- 7 weeks ago - Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 7 weeks ago - Jade Biosciences Proxy statement: Proxy filing - Filings
- 7 weeks ago - Jade Biosciences 10M share Secondary priced at $15.00 - TheFly
- 7 weeks ago - Jade Biosciences Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Jade Biosciences announces common stock offering, no amount given - TheFly
- 7 weeks ago - Jade Biosciences Announces Proposed Underwritten Public Offering - GlobeNewsWire